Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System from the United States Food and Drug ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Smith & Nephew received FDA 510(k) clearance for the ...
Smith+Nephew announces its CORIOGRAPH Pre-Op Planning and Modeling Services is now cleared for total hip arthroplasty by the United States Food and Drug Administration. Exclusively for users of the ...
The latest round in the spine, hip, and knee segment's M&A dance has ended with Stryker Corp. admitting that it has its eye on Smith & Nephew plc but isn't ready to pop the question yet. Meanwhile, ...